Description: This session will present results of the most recent SOA/LIMRA studies of variable and fixed-indexed annuity policyholder behavior including withdrawal behavior, guaranteed living benefit elections and surrender activity. Conducted annually since 2006, a discussion on the results of these studies show how they have changed over time, as well as areas where the analysis will need to change or expand. After that, the presenters will focus on dynamic lapse for hot money businesses, which is an important topic for fixed deferred annuity. Key takeaways from this area will include an understanding how to differentiate between hot money and warm money, the different formulas used in the industry, and how to adjust an asset portfolio to protect against the risks associated with hot money businesses.

Description: Back in the day, when data was scarce and computers were slow, actuaries were forced to use simple methods to account for risk. By far, the most common method was to add a margin, usually 5% to a “best estimate” calculation. Remarkedly, this method still works quite well in the aggregate. The problem is that, in many cases, decisions today require a more in-depth analysis. For example, how big a risk is a health plan really taking if it lowers its premiums by 10% to attract more members? This session will discuss techniques for measuring risk in today’s environment. Speakers will also share the results from the 5/50 research project, which forms the foundation for the techniques.

Description: 2021 ImpACT Conference - Session 3A: Cyber: How Many Risk Categories Does it Cross? 10.26.21 Recording

Description: 2021 ImpACT Conference -Session 9D: How Good Are Your Risk Disclosures? A Comparative Analysis 10.28.21 Recording

Description: Participate in a discussion with panelists from various functional areas andcompanies about the trend of increasing mutual attractions between private equity and insurance companies, the underlying strategic drivers from both sides, as well as the impact to both individual insurance companies and insurance industry as a whole. Take part in a conversation about the implications of insurers' obligations/changes to risk profiles and exposures when engaging offshore domicile of affiliated and unaffiliated reinsurers involved in the private equity-owned insurance business.

Description: In light of recent regulatory developments and international best practices, the Bermuda Monetary Authority has introduced proposed enhancements to the Bermuda regulatory framework for long-term commercial insurers. During this panel discussion, discuss the potential impacts of these proposed regulatory changes for existing commercial insurers and new entrants to the Bermuda life reinsurance market.

Description: "Hear AM Best rating analysts discuss the rating process and the best capital adequacy ratio (BCAR), a quantitative foundation for AM Best’s assessment of carriers’ financial strength. The benchmarking of BCAR scores for various company types (national MCOs, BCBS plans, smaller regional plans) will be discussed. Look at how changes in investment and underwriting environment impacted the results over the past several years. Further, AM Best’s view of the quality of capital and various factors impacting the overall assessment of the balance sheet strength will be discussed. By attending this session, you will: Gain an understanding of AM Best’s building block approach to ratings and how the BCAR results fit into the process. Learn the differences between RBC and BCAR models. Learn how various factors—e.g. liquidity, financial flexibility, financial leverage, the org structure—impact the final AM Best assessment of health companies' capital."

Description: With seemingly unending demands on life & annuity companies for more intense and complex calculations, as well as greater sophistication around analytics, and all of this done at speed, never before has it been so important to seek out maximum efficiency in constructing models. In this session the panelists examine how the combination of various model efficiency approaches, pulling in many different facets of modeling and making it flexible enough to dial up or down various modeling components, can bring about incredible results. Not only does it become possible to produce and expand upon financial risk metrics via a building block approach, but also enables life insurers to produce analytics and dashboards to support strategic decisions that were simply not possible or cost effectively viable before.

Description: The working life of actuaries has become faster paced, more complex, and potentially more volatile than in any previous period in the history of the profession. Furthermore, actuaries are increasingly being asked to expand their roles into areas that lie beyond the traditional space associated with the actuarial profession. As a result, actuaries are increasingly finding themselves faced with professional and ethical dilemmas for which there is little precedent to rely for guidance. Take part in a guided discussion about three real-world case studies where actuaries were required to make difficult decisions. We will see how by remaining calm and leaning on the ASOPs, actuaries were able to navigate professional and ethical pitfalls despite pressure from key stakeholders. Each case study will highlight actuaries working in different areas within the industry. Some examples may include: - Case study 1: An actuary working for a direct insurer finds a last-minute error during a busy production cycle. - Case study 2: An actuary working for a reinsurer finds themselves under pressure to apply an unrealistic assumption. - Case study 3: An actuarial consultant is under pressure from a non-actuarial client to perform work in a way that would not comply with actuarial standards. By attending the session, you will: - Understand how to lean on the ASOPs to keep cool during stressful situations. - Manage deadlines and expectations. - Balance risk and reward, and remain true professionals, no matter how hot the fire.

Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.